Scientists at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University will test Guardant Health’s technology to detect cancer at early stages in high-risk populations.
Browsing: Disease Discoveries
Mutations in a gene called TMEM230 were definitively linked to confirmed cases of the common movement disorder in a recent Northwestern Medicine study.
A new study identified a link between gene expression levels and protein aggregation, which can lead to neurodegenerative disorders.
Navdeep Chandel, PhD, David W. Cugell Professor of Medicine, has received the National Cancer Institute’s Outstanding Investigator Award to explore how mitochondrial metabolism plays a role in cancer.
Certain anatomical properties of the brain – not the initial injury – determine most of a patient’s risk of developing chronic pain, according to a new study.
The results of a recent study co-authored by C. David James, PhD, uncovered potential new targets for treating glioblastoma, a fatal brain tumor for which there is currently no cure.
Scientists have created a glowing map of the very first cells to be infected with an HIV-like virus, pinpointing the vulnerable points where HIV may enter the female reproductive tract.
A biodegradable nanoparticle can hide an allergen in a friendly shell to convince the immune system not to attack it, according to new Northwestern Medicine research.
New Northwestern Medicine research has shown that reprogrammed stem cells can be used to identify patients with cancer who are likely to experience a dangerous side effect of a common chemotherapy drug.
Suboptimal social and educational outcomes among young adults with childhood epilepsy persist even when seizures are under control and the disease is in remission, according to a recent study.